Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
Public ClinicalTrials.gov record NCT02201524. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study B7451005 is a Phase 2 study which will assess the efficacy and safety of PF-04965842 in patients with moderate to severe psoriasis. The study will include three PF-04965842 groups (200 mg daily, 400 mg daily and 200 mg twice daily) and a placebo group. The treatment period will be 4 weeks in duration and will be followed up by a 4 week follow up period.
Study identification
- NCT ID
- NCT02201524
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2014 (Type not available)
- Primary completion
- Sep 2015 (Actual)
- Completion
- Sep 2015 (Actual)
- Last update posted
- Oct 5, 2016
2014 – 2015
United States locations
- U.S. sites
- 35
- U.S. states
- 19
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Dermatology Center, PC | Birmingham | Alabama | 32505 | — |
| Northwest Arkansas Clinical Trials Center, PLLC/Hull Dermatology, PA | Rogers | Arkansas | 72758 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Dermatology Specialists, Inc. | Oceanside | California | 92056 | — |
| Huntington Medical Foundation/Specialty Office | Pasadena | California | 91105 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Olympian Clinical Research | Clearwater | Florida | 33756 | — |
| Westcoast Radiology Services | Clearwater | Florida | 33756 | — |
| North Florida Dermatology Associates, PA | Jacksonville | Florida | 32204 | — |
| International Dermatology Research, Inc. | Miami | Florida | 33144 | — |
| Park Avenue Dermatology, PA | Orange Park | Florida | 32073 | — |
| Leavitt Medical Associates of Florida d/b/a Ameriderm Research | Ormond Beach | Florida | 32174 | — |
| Advanced Medical Research, Inc | Atlanta | Georgia | 30342 | — |
| Columbus Dermatology, P.C. | Columbus | Georgia | 31904 | — |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | — |
| Dundee Dermatology | West Dundee | Illinois | 60118 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46256 | — |
| Dawes Fretzin Dermatology Group, LLC | Indianapolis | Indiana | 46256 | — |
| DS Research | Louisville | Kentucky | 40202 | — |
| Shondra L Smith, MD | Lake Charles | Louisiana | 70605 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01605 | — |
| Dartmouth-Hitchcock Medical Center - Section of Dermatology | Lebanon | New Hampshire | 03756 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| Duke University Medical Center - Shipment Only | Durham | North Carolina | 27710 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Arlington Research Center, Inc. | Arlington | Texas | 76011 | — |
| Dermatology Treatment & Research Center, PA | Dallas | Texas | 75230 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Virginia Clinical Research | Norfolk | Virginia | 23507 | — |
| Premier Clinical Research | Spokane | Washington | 99202-1480 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02201524, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2016 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02201524 live on ClinicalTrials.gov.